Hormone receptors in defining breast cancer prognosis--time for a rethink?
Speirs
Valerie
V
Leeds Institute of Molecular Medicine, Wellcome Trust Brenner Building, St James's University Hospital, Beckett Street, Leeds LS9 7TK, UK. v.speirs@leeds.ac.uk
Shaaban
Abeer M
AM
D001943:Breast Neoplasms / Q000737:chemistry* / Q000378:metabolism / Q000628:therapy; D047628:Estrogen Receptor alpha / Q000032:analysis* / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000032:analysis* / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D020411:Oligonucleotide Array Sequence Analysis; D018579:Patient Selection; D011379:Prognosis; D011980:Receptors, Progesterone / Q000032:analysis* / Q000378:metabolism
D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D011980:Receptors, Progesterone